APA Style
BREHLER, RANDOLF, ECKARD HAMELMANN, LUDGER KLIMEK, CHRISTIAN VOGELBERG, THOMAS WERFEL, OLIVER PFAAR. (2016).
Evidence vs. efficacy in allergen-speci c immunotherapy: Considerations using the example of tradable products in Germany (Allergo J Int 2016; 25:38–43).
German:
Springer.
Chicago Style
BREHLER, RANDOLF, ECKARD HAMELMANN, LUDGER KLIMEK, CHRISTIAN VOGELBERG, THOMAS WERFEL, OLIVER PFAAR.
Evidence vs. efficacy in allergen-speci c immunotherapy: Considerations using the example of tradable products in Germany.
Allergo J Int 2016; 25:38–43
German:
Springer,
2016.
Artikel.
MLA Style
BREHLER, RANDOLF, ECKARD HAMELMANN, LUDGER KLIMEK, CHRISTIAN VOGELBERG, THOMAS WERFEL, OLIVER PFAAR.
Evidence vs. efficacy in allergen-speci c immunotherapy: Considerations using the example of tradable products in Germany.
Allergo J Int 2016; 25:38–43
German:
Springer,
2016.
Artikel.
Turabian Style
BREHLER, RANDOLF, ECKARD HAMELMANN, LUDGER KLIMEK, CHRISTIAN VOGELBERG, THOMAS WERFEL, OLIVER PFAAR.
Evidence vs. efficacy in allergen-speci c immunotherapy: Considerations using the example of tradable products in Germany.
Allergo J Int 2016; 25:38–43
German:
Springer,
2016.
Artikel.